Clinical trial
Efficacy and Safety of Mydriatic Microdrops for Retinopathy Of Prematurity Screening: a Non-inferiority Crossover Randomized Controlled Trial (MyMiROPS Trial)
NCT05043077 is registered in ClinicalTrials.gov with Aristotle University Of Thessaloniki as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Mydriatic Microdrops for Retinopathy Of Prematurity Screening: a Non-inferiority Crossover Randomized Controlled Trial (MyMiROPS Trial)
- Lead sponsor
- Aristotle University Of Thessaloniki
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- September 7, 2021
- Completion date
- January 23, 2023
- Enrollment
- 83 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.